Schott, Jonathan M.

Blood Biomarkers for Alzheimer’s Disease: Much Promise, Cautious Progress

Keshavan, A., Heslegrave, A., Zetterberg, H., & Schott, J. M. (2017) · Molecular Diagnosis & Therapy

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 34

Altered body schema processing in frontotemporal dementia with C9ORF72 mutations

Downey, L. E., Fletcher, P. D., Golden, H. L., Mahoney, C. J., Agustus, J. L., Schott, J. M., Rohrer, J. D., Beck, J., Mead, S., Rossor, M. N., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry

Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research

Cited by 34

Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study

Cabreira, V., Alty, J., Antic, S., Araújo, R., Aybek, S., Ball, H. A., Baslet, G., Bhome, R., Coebergh, J., Dubois, B., et al. (2025) · European Journal of Neurology

Psychosomatic Disorders and Their TreatmentsDementia and Cognitive Impairment Research

Cited by 24

Towards cascading genetic risk in Alzheimer’s disease

Altmann, A., Aksman, L. M., Oxtoby, N. P., Young, A. L., ADNI, Weiner, M., Aisen, P., Petersen, R., Weiner, M., Aisen, P., et al. (2024) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 18

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7

O2‐05‐01: A DATA‐DRIVEN MODEL OF BIOMARKER CHANGES IN SPORADIC ALZHEIMER'S DISEASE

Young, A. L., Oxtoby, N. P., Daga, P., Cash, D. M., Fox, N., Ourselin, S., Schott, J. M., & Alexander, D. C. (2014) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 2

Short-interval variability and test-retest reliability of Alzheimer’s disease plasma biomarkers in a clinically heterogenous cohort

Beament, M., Wiltshire, K., Belder, C. R. S., Abel, E., Hart, M., Heslegrave, A. J., Lunn, M. P., Rosa-Grilo, M., Swann, O., Schott, J. M., et al. (2026) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 0